Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC

Malnutrition is highly prevalent in patients with upper gastrointestinal tumors, which may negatively impact treatment tolerance and anti-tumor immune responses. This study aims to evaluate the efficacy and safety of intensive enteral nutritional support in patients with locally advanced unresectable esophageal squamous cell carcinoma (ESCC) undergoing conversion therapy. Participants receiving PD-1 inhibitors combined with chemotherapy will be randomly assigned to either intensive nutritional support or standard care. The primary goal is to determine if intensive nutritional support can impro

Trial Details

NCT ID
NCT07519486
Phase
PHASE2
Sponsor
Sichuan University
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • PD-1 Inhibitor plus Chemotherapy
  • Oral Enteral Nutritional Preparation
  • Esophagectomy with lymph node dissection
Locations (sample)
  • Chengdu, Sichuan, China|30.66667,104.06667

Key Eligibility Criteria

  • Pathologically confirmed Esophageal Squamous Cell Carcinoma (ESCC). Aged 18-80 years, regardless of gender. ECOG Performance Status (PS) 0-2, and w…
  • Confirmed locally advanced unresectable ESCC according to NCCN Guidelines (Version 2026.1).
  • Planned to receive surgery after completion of conversion therapy, with no surgical contraindications.
  • Treatment-naive: No prior anti-tumor therapy for ESCC, including radiotherapy, chemotherapy, or surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →